Financial Perspectives’s Avanos Medical AVNS Stock Holding History

Financial Perspectives’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-209	Closed	-$2.42K	–	718
2025 Q3	$2.42K	Hold	209	–	–	﹤0.01%	629
2025 Q2	$2.56K	Hold	209	–	–	﹤0.01%	620
2025 Q1	$3K	Hold	209	–	–	﹤0.01%	599
2024 Q4	$3.33K	Hold	209	–	–	﹤0.01%	595
2024 Q3	$5.02K	Hold	209	–	–	﹤0.01%	523
2024 Q2	$4.16K	Hold	209	–	–	﹤0.01%	530
2024 Q1	$4.16K	Hold	209	–	–	﹤0.01%	525
2023 Q4	$4.69K	Hold	209	–	–	﹤0.01%	533
2023 Q3	$4.23K	Hold	209	–	–	﹤0.01%	528
2023 Q2	$5.34K	Hold	209	–	–	﹤0.01%	506
2023 Q1	$6.22K	Hold	209	–	–	﹤0.01%	491
2022 Q4	$5.66K	Hold	209	–	–	﹤0.01%	501
2022 Q3	$4.55K	Hold	209	–	–	﹤0.01%	513
2022 Q2	$5.71K	Hold	209	–	–	﹤0.01%	498
2022 Q1	$7K	Hold	209	–	–	﹤0.01%	503
2021 Q4	$7.25K	Hold	209	–	–	﹤0.01%	472
2021 Q3	$6.52K	Hold	209	–	–	﹤0.01%	482
2021 Q2	$7.6K	Sell	209 -8,933	-98%	-$369K	﹤0.01%	490
2021 Q1	$209K	Buy	9,142 +8,933	+4,274%	+$419K	0.01%	396
2020 Q4	$9.59K	Hold	209	–	–	0.01%	410
2020 Q3	$6.94K	Hold	209	–	–	﹤0.01%	395
2020 Q2	$6.14K	Hold	209	–	–	﹤0.01%	394
2020 Q1	$5.63K	Hold	209	–	–	﹤0.01%	375
2019 Q4	$7.04K	Buy	+209	New	+$7.57K	﹤0.01%	366

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Perspectives's AVNS Position: Q4 2025 in Review

Financial Perspectives sold out of Avanos Medical (AVNS) in Q4 2025, closing a stake of 209 shares — an estimated $2.42K sold.

Financial Perspectives first reported a position in AVNS in Q4 2019 and held it in 24 quarters. The position peaked at $209K in Q1 2021. 274 funds tracked by Wall St. Rank hold AVNS as of Q4 2025.

Financial Perspectives reported no remaining Avanos Medical position as of Q4 2025 after selling out during the quarter.
Financial Perspectives sold 209 Avanos Medical shares in Q4 2025, an estimated $2.42K.
Financial Perspectives first reported a position in Avanos Medical in Q4 2019 and held it in 24 quarters.
Financial Perspectives's Avanos Medical position peaked at $209K in Q1 2021.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2025.

Based on Financial Perspectives's 13F filing for Q4 2025, filed 28 Jan 2026.